Artificial Intelligence (AI) in Drug Discovery Market is Booming at a CAGR of 40.7% by 2026 | Exscientia, Benevolentai, Insilico Medicine, Deep Genomics, etc.

The following report contains all the statistics and facts & figures related to the global Artificial Intelligence (AI) in Drug Discovery market. For this reason, the biopharmaceutical industries are increasingly adopting AI technology to optimize the drug manufacturing process. For instance, as per India Brand Equity Foundation, 2018, the Indian Government is planning a $640 million fund for boosting the drug discovery and pharmaceutical infrastructure. The initiative 'Pharma Vision 2020' of Indian Government has a goal for making India a major hub for drug discovery. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. Our trusted publishers have compiled their reports and findings after painstaking research and studies, set up against varied business parameters. Use of stem cells from cord blood is increasing, as it does not require perfect human leukocyte antigen (HLA) tissue matching, can be used allogenically, and has less incidence of graft v/s host disease. Munich, Germany, November 23, 2017 - vermicon AG, the specialist for microbiological solutions, is launching the new Scan VIT® system for analysis of microorganisms. A fully automated analysis evaluation is provided by the intelligent VIT® Vision software, which is the centerpiece of the new, patented technology.